Sunil Badve

About Professor Sunil Badve

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

Professor Sunil Badve is a senior staff specialist nephrologist at St. George Hospital, Sydney and Conjoint Professor at UNSW Medicine and Health. His medical education has been at the University of Mumbai and the University of Ottawa. He also has a PhD from the University of Queensland. He is a fellow of the American Society of Nephrology.

Professor Badve’s primary research focus is in clinical trials, meta-analyses and epidemiology, particularly in progression of chronic kidney disease, anticoagulation and treatment of cardiovascular disease in chronic kidney disease. He has received more than $12 million NHMRC research funding as a chief investigator.

Professor Badve is the Nephrology Subspecialty Editor for the Internal Medicine Journal and serves on the Editorial Board of the American Journal of Kidney Diseases.

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases

JAMA Date published:

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease

JAMA Date published:

Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) Trial

American Journal of Nephrology Date published:

SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2

Journal of Cardiac Failure Date published:

Related Readings